Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).

@article{Montalescot2003StentingAG,
  title={Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).},
  author={Gilles Montalescot and Frans Van de Werf and Dietrich C. Gulba and Alvaro A Avezum and David Brieger and Brian M Kennelly and Tomasz Mazurek and Frederick Spencer and Kami White and Joel M. Gore},
  journal={Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions},
  year={2003},
  volume={60 3},
  pages={360-7}
}
Stenting and GP IIb/IIIa inhibition are promising adjunctive therapies in PCI. The Global Registry of Acute Coronary Events (GRACE) is a registry of unselected patients with acute coronary syndromes, allowing for the study of treatments in a real-world environment. Data from GRACE patients with AMI who underwent PCI were analyzed. After adjusting for demographics, baseline characteristics, and previous medications, treatment with GP IIb/IIIa inhibitors and a stent and treatment with a stent… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.